Imagion Biosystems has released Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations.
Read Appendix 4G
The Stock Network Interview – How MagSense® is moving towards Phase 2 clinical trials
September 4, 2026
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how the company is moving through the critical steps required